Total Payments
$20,798
2024 Payments
$2,142
Companies
54
Transactions
1,339
Medicare Patients
2,066
Medicare Billing
$403,974
Payment Breakdown by Category
Food & Beverage$20,337 (97.8%)
Education$461.34 (2.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $20,337 | 1,327 | 97.8% |
| Education | $461.34 | 12 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $2,503 | 221 | $0 (2024) |
| ABBVIE INC. | $2,132 | 137 | $0 (2024) |
| Janssen Biotech, Inc. | $1,986 | 211 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,946 | 83 | $0 (2024) |
| Amgen Inc. | $1,406 | 76 | $0 (2024) |
| Lilly USA, LLC | $1,359 | 91 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,144 | 71 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $897.63 | 49 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $782.94 | 40 | $0 (2024) |
| UCB, Inc. | $695.19 | 33 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,142 | 101 | AstraZeneca Pharmaceuticals LP ($547.62) |
| 2023 | $2,186 | 131 | AbbVie Inc. ($281.86) |
| 2022 | $3,147 | 170 | Janssen Biotech, Inc. ($441.38) |
| 2021 | $2,818 | 181 | PFIZER INC. ($451.70) |
| 2020 | $2,950 | 169 | PFIZER INC. ($447.30) |
| 2019 | $2,774 | 193 | PFIZER INC. ($339.91) |
| 2018 | $1,979 | 161 | PFIZER INC. ($234.65) |
| 2017 | $2,802 | 233 | AbbVie, Inc. ($361.63) |
All Payment Transactions
1,339 individual payment records from CMS Open Payments — Page 1 of 54
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $39.76 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $3.59 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: NEUROSCIENCE | ||||||
| 12/16/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/12/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $21.77 | General |
| 12/11/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $35.21 | General |
| Category: Immunology | ||||||
| 12/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $34.42 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 11/21/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $0.84 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $31.34 | General |
| Category: RESPIRATORY | ||||||
| 11/20/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.45 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $27.37 | General |
| Category: Inflammation | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Respiratory | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $32.44 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | Genentech USA, Inc. | Actemra (Biological) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Immunology | ||||||
| 10/16/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Immunology | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 10/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $3.92 | General |
| Category: RESPIRATORY | ||||||
| 10/09/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $28.39 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $17.68 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 357 | 690 | $57,129 | $29,213 |
| 2022 | 13 | 521 | 747 | $68,672 | $33,051 |
| 2021 | 16 | 600 | 2,570 | $341,824 | $106,630 |
| 2020 | 13 | 588 | 5,374 | $915,861 | $235,081 |
Total Patients
2,066
Total Services
9,381
Medicare Billing
$403,974
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 132 | 209 | $27,002 | $17,172 | 63.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 36 | 36 | $12,600 | $4,349 | 34.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 41 | 60 | $7,200 | $3,302 | 45.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 17 | 17 | $3,642 | $2,110 | 57.9% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 24 | 41 | $2,195 | $1,410 | 64.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 32 | 61 | $1,830 | $631.80 | 34.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 60 | 243 | $2,430 | $210.29 | 8.7% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 15 | 23 | $230.00 | $28.15 | 12.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 128 | 221 | $28,465 | $17,237 | 60.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 51 | 51 | $16,519 | $6,285 | 38.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 52 | 70 | $8,400 | $3,492 | 41.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 15 | 15 | $3,232 | $1,898 | 58.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 29 | 44 | $2,241 | $1,590 | 71.0% |
| 20550 | Injection into tendon or ligament | Office | 2022 | 20 | 24 | $2,400 | $806.33 | 33.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 45 | 86 | $2,920 | $757.29 | 25.9% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 27 | 27 | $607.10 | $468.88 | 77.2% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 20 | 21 | $1,365 | $204.74 | 15.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 20 | 21 | $823.68 | $157.80 | 19.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 74 | 118 | $1,210 | $85.20 | 7.0% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 28 | 37 | $370.00 | $40.68 | 11.0% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 12 | 12 | $120.00 | $27.92 | 23.3% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2021 | 13 | 1,680 | $226,800 | $57,983 | 25.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 140 | 237 | $37,887 | $22,054 | 58.2% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2021 | 24 | 65 | $30,588 | $7,354 | 24.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 47 | 47 | $13,930 | $6,097 | 43.8% |
About Dr. Jihad Abialmouna, M.D
Dr. Jihad Abialmouna, M.D is a Rheumatology healthcare provider based in West Amherst, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1396793782.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jihad Abialmouna, M.D has received a total of $20,798 in payments from pharmaceutical and medical device companies, with $2,142 received in 2024. These payments were reported across 1,339 transactions from 54 companies. The most common payment nature is "Food and Beverage" ($20,337).
As a Medicare-enrolled provider, Abialmouna has provided services to 2,066 Medicare beneficiaries, totaling 9,381 services with total Medicare billing of $403,974. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location West Amherst, NY
- Active Since 05/05/2006
- Last Updated 03/05/2009
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1396793782
Products in Payments
- XELJANZ (Drug) $1,201
- ACTHAR (Biological) $1,200
- JARDIANCE (Drug) $994.08
- SIMPONI ARIA (Biological) $952.59
- Enbrel (Biological) $892.75
- RINVOQ (Biological) $682.12
- BENLYSTA (Biological) $679.14
- Humira (Biological) $673.52
- Cimzia (Drug) $659.98
- SAPHNELO (Biological) $643.65
- TREMFYA (Drug) $643.62
- Rituxan (Biological) $460.61
- Otezla (Drug) $426.67
- KRYSTEXXA (Biological) $418.57
- AIRSUPRA (Drug) $416.08
- FARXIGA (Drug) $402.35
- TALTZ (Drug) $376.18
- REMICADE (Biological) $369.97
- RAYOS (Drug) $350.50
- COLOGUARD (Device) $311.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.